Scientists Don’t Fear a New Crispr Snag – Bloomberg
Bloomberg |
Scientists Don't Fear a New Crispr Snag
Bloomberg Porteus himself is working with FDA to start clinical trials of a Crispr-based therapy for sickle cell disease. The key difference between Crispr and more traditional gene therapy, he said, is in its precision. The original version of gene therapy … China Is Way Ahead When It Comes To CRISPR Gene Editing CRISPR first in US: Human cancer patients to be treated with gene-editing tool |
